Steven K. Burke, M.D., is a distinguished medical professional currently serving as the Senior Vice President and Chief Medical Officer at Akebia Therapeutics Inc. Dr. Burke has an extensive background in nephrology and clinical development, making him a valuable asset to Akebia, a biopharmaceutical company focused on developing innovative treatments for kidney disease and related conditions. Before joining Akebia, Dr. Burke held several leadership positions in the pharmaceutical industry, where he spearheaded the development of numerous successful clinical programs. Dr. Burke's career is marked by significant achievements in the field of nephrology. He has been instrumental in the development and approval of several groundbreaking therapies that have improved the lives of patients with kidney diseases. His expertise in clinical trial design and execution has been pivotal in advancing the field, and his work has been widely recognized and published in leading medical journals. At Akebia, Dr. Burke leads the medical affairs and clinical development teams, overseeing the company's pipeline of novel therapeutics aimed at addressing unmet needs in kidney health. In his role as Chief Medical Officer, Dr. Burke is responsible for guiding the strategic direction of Akebia's clinical programs and ensuring the highest standards of patient care and safety. His leadership has been crucial in navigating the complex regulatory landscape and bringing innovative treatments to market. Dr. Burke's dedication to advancing kidney care and his ability to foster collaboration across multidisciplinary teams have solidified his reputation as a visionary leader in the biopharmaceutical industry.